STRAGEN was founded in 1990 and began its activity in the field of APIs, which quickly evolved into the development, registration, and distribution of finished generics marketed today in over 60 countries. Today, STRAGEN is a global health care company based in Geneva, Switzerland, focused on the development of niche generic pharmaceuticals, consumer health products, and drug development programmes. STRAGEN continues to grow by developing new products and expanding its international presence through a network of partners, exclusive distributors, and new affiliate offices.